DCTHD

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/14/2017
Contact Info
  • 1633 Broadway
  • Suite 22C
  • New York, NY 10019

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000872912
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Jennifer Kate Simpson CEO
Barbra C Keck CFO
John Purpura EVP, Ops.
Janetta Trochimiuk Controller
Company Directors
Roger G. Stoll Chairman
William D. Rueckert
Marco Taglietti
Service Providers
Accounting/Auditing Firm
Grant Thornton
666 Third Avenue
New York, NY, 10017
United States

Legal Counsel
Wexler Burkhart Hirschberg & Unger, LLP
377 Oak St.
Concourse Level
Garden City, NJ, 11530
United States

Investor Relations Firm
CoreIR
377 Oak Street - Concourse 2
Garden City, NY, 11530
United States

DCTHD Security Details
Share Structure
Market Value1 $1,030,125 a/o Nov 21, 2017
Authorized Shares Not Available
Outstanding Shares 2,591,509 a/o Nov 13, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders
Shareholders of Record 34 a/o Mar 29, 2017
Short Selling Data
Short Interest 3,305,689 (-77.68%)
Oct 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security